Your browser doesn't support javascript.
loading
Βeta-catenin N-terminal domain: An enigmatic region prone to cancer causing mutations.
Dar, Mohd Saleem; Singh, Paramjeet; Mir, Riyaz A; Dar, Mohd Jamal.
Afiliação
  • Dar MS; Academy of Scientific and Innovative Research (AcSIR), New Delhi, India; Cancer Pharmacology Division, CSIR-Indian Institute of Integrative Medicine, Jammu, J&K, India.
  • Singh P; Academy of Scientific and Innovative Research (AcSIR), New Delhi, India; Cancer Pharmacology Division, CSIR-Indian Institute of Integrative Medicine, Jammu, J&K, India.
  • Mir RA; Department of Biochemistry, All India Institute of Medical Sciences (AIIMS), Ansari Nagar, New Delhi, India.
  • Dar MJ; Academy of Scientific and Innovative Research (AcSIR), New Delhi, India; Cancer Pharmacology Division, CSIR-Indian Institute of Integrative Medicine, Jammu, J&K, India. Electronic address: jamal@iiim.res.in.
Mutat Res Rev Mutat Res ; 773: 122-133, 2017 Jul.
Article em En | MEDLINE | ID: mdl-28927523
ABSTRACT
The Wnt/ß-catenin is a highly conserved signaling pathway involved in cell fate decisions during various stages of development. Dysregulation of canonical Wnt/ß-catenin signaling has been associated with various diseases including cancer. ß-Catenin, the central component of canonical Wnt signaling pathway, is a multi-functional protein playing both structural and signaling roles. ß-Catenin is composed of three distinct domains N-terminal domain, C-terminal domain and a central armadillo repeat domain. N-terminal domain of ß-catenin harbours almost all of the cancer causing mutations, thus deciphering its critical structural and functional roles offers great potential in cancer detection and therapy. Here, in this review, we have collected information from pharmacological analysis, bio-physical and structural studies, molecular modeling, in-vivo and in-vitro assays, and transgenic animal experiments employing various N-terminal domain variants of ß-catenin to discuss the interaction of ß-catenin with its binding partners that specifically interact with this domain and the implications of these interactions on signaling, cell fate determination, and in tumorigenesis. A thorough understanding of interactions between ß-catenin and its binding partners will enable us to more effectively understand how ß-catenin switches between its multiple roles, and will lead to the development of specific assays for the identification of small molecules as chemotherapeutic agents to treat diseases, including cancer and neurological disorders, where Wnt/ß-catenin signaling is dysregulated.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Beta Catenina / Neoplasias Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Mutat Res Rev Mutat Res Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Índia

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Beta Catenina / Neoplasias Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Mutat Res Rev Mutat Res Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Índia